©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7728-7737
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7728
Table 1 Clinical characteristics
| Characteristics | Number (n) | Percent (%) |
| Median age (yr) | 59 | |
| Age range (yr) | 26-82 | |
| Sex | ||
| Male | 33 | 54 |
| Female | 28 | 46 |
| Treatment area | ||
| Head and neck | 12 | 20 |
| Chest | 13 | 21 |
| Abdomen | 10 | 16 |
| Pelvic | 14 | 23 |
| Spine and bone | 12 | 20 |
| Treatment type | ||
| Primary tumour | 34 | 56 |
| Recurrence in situ | 1 | 1 |
| Metastasis | 26 | 43 |
| Radiation technology | ||
| IMRT | 21 | 35 |
| VMAT | 39 | 64 |
| SRT | 1 | 1 |
| Concurrent therapy | ||
| Chemotherapy | 15 | |
| Other1 | 15 | |
| No | 31 | |
| Radiation toxicities | ||
| No | 23 | 38 |
| Cured after treatment | 34 | 56 |
| Yes | 4 | 6 |
- Citation: Wang GY, Zhu QZ, Zhu HL, Jiang LJ, Zhao N, Liu ZK, Zhang FQ. Clinical performance evaluation of O-Ring Halcyon Linac: A real-world study. World J Clin Cases 2022; 10(22): 7728-7737
- URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7728.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i22.7728